» Articles » PMID: 35723326

Mesenchymal Stem Cells in the Treatment of Human Spinal Cord Injury: The Effect on Individual Values of PNF-H, GFAP, S100 Proteins and Selected Growth Factors, Cytokines and Chemokines

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2022 Jun 20
PMID 35723326
Authors
Affiliations
Soon will be listed here.
Abstract

At present, there is no effective way to treat the consequences of spinal cord injury (SCI). SCI leads to the death of neural and glial cells and widespread neuroinflammation with persisting for several weeks after the injury. Mesenchymal stem cells (MSCs) therapy is one of the most promising approaches in the treatment of this injury. The aim of this study was to characterize the expression profile of multiple cytokines, chemokines, growth factors, and so-called neuromarkers in the serum of an SCI patient treated with autologous bone marrow-derived MSCs (BM-MSCs). SCI resulted in a significant increase in the levels of neuromarkers and proteins involved in the inflammatory process. BM-MSCs administration resulted in significant changes in the levels of neuromarkers (S100, GFAP, and pNF-H) as well as changes in the expression of proteins and growth factors involved in the inflammatory response following SCI in the serum of a patient with traumatic SCI. Our preliminary results encouraged that BM-MSCs with their neuroprotective and immunomodulatory effects could affect the repair process after injury.

Citing Articles

The neuroprotective effect of quercetin nanoparticles in the therapy of neuronal damage stimulated by acrolein.

Sanad S, Farouk R, Nassar S, Alshahrani M, Suliman M, Ahmed A Saudi J Biol Sci. 2023; 30(11):103792.

PMID: 37711970 PMC: 10498005. DOI: 10.1016/j.sjbs.2023.103792.


Ferroptosis and mitochondrial dysfunction in acute central nervous system injury.

Dong W, Gong F, Zhao Y, Bai H, Yang R Front Cell Neurosci. 2023; 17:1228968.

PMID: 37622048 PMC: 10445767. DOI: 10.3389/fncel.2023.1228968.


The Role of Mesenchymal Stromal Cells and Their Products in the Treatment of Injured Spinal Cords.

Slovinska L, Harvanova D Curr Issues Mol Biol. 2023; 45(6):5180-5197.

PMID: 37367078 PMC: 10297479. DOI: 10.3390/cimb45060329.

References
1.
Zhou Z, Peng X, Insolera R, Fink D, Mata M . Interleukin-10 provides direct trophic support to neurons. J Neurochem. 2009; 110(5):1617-27. PMC: 2737090. DOI: 10.1111/j.1471-4159.2009.06263.x. View

2.
Kim D, Staples M, Shinozuka K, Pantcheva P, Kang S, Borlongan C . Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013; 14(6):11692-712. PMC: 3709752. DOI: 10.3390/ijms140611692. View

3.
Kanno H, Pearse D, Ozawa H, Itoi E, Bunge M . Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus. Rev Neurosci. 2015; 26(2):121-8. DOI: 10.1515/revneuro-2014-0068. View

4.
ZuK P, Zhu M, Ashjian P, De Ugarte D, Huang J, Mizuno H . Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13(12):4279-95. PMC: 138633. DOI: 10.1091/mbc.e02-02-0105. View

5.
Secunda R, Vennila R, Mohanashankar A, Rajasundari M, Jeswanth S, Surendran R . Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology. 2014; 67(5):793-807. PMC: 4545441. DOI: 10.1007/s10616-014-9718-z. View